Cargando…

Case report: Highly differentiated endometrial adenocarcinoma that collided with uterine cervical carcinosarcoma

Uterine collision tumor is a rare pathological type composed of two or more malignant tumors. The components of these malignant tumors do not have histological mixing and are separated by the normal mesenchyme. Collision cancer is very rare, with uterine collision tumors being even rarer. Only a few...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Xue, Hu, Haoyue, Liu, Yang, Tan, Songtao, Xie, Meng, Zhang, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909557/
https://www.ncbi.nlm.nih.gov/pubmed/36778737
http://dx.doi.org/10.3389/fmed.2023.1044196
_version_ 1784884602354008064
author Fan, Xue
Hu, Haoyue
Liu, Yang
Tan, Songtao
Xie, Meng
Zhang, Fang
author_facet Fan, Xue
Hu, Haoyue
Liu, Yang
Tan, Songtao
Xie, Meng
Zhang, Fang
author_sort Fan, Xue
collection PubMed
description Uterine collision tumor is a rare pathological type composed of two or more malignant tumors. The components of these malignant tumors do not have histological mixing and are separated by the normal mesenchyme. Collision cancer is very rare, with uterine collision tumors being even rarer. Only a few cases have been reported in relation to uterine collision tumors. At present, there is no standard treatment guideline for uterine collision tumors, and a comprehensive treatment composed of surgery, radiotherapy, and chemotherapy is suggested. In this study, we report a 54-year-old female patient diagnosed with highly differentiated endometrial adenocarcinoma with cervical carcinosarcoma. The endometrial adenocarcinoma component invaded the deep myometrium (> 1/2 layer), involving the cervical glands and interstitium. The regional lymph node metastasis from endometrial adenocarcinoma was also detected. The patient underwent “transabdominal tumor cytoreduction (total hysterectomy + right adnexal resection + greater omentectomy + pelvic lymph node dissection + para-aortic lymph node dissection) + pelvic adhesion release.” In addition, she has completed adjuvant radiotherapy and chemotherapy. After reviewing previous reports of collision tumors in different positions of the uterus, we found that collision tumors between the cervix and uterine body are very uncommon. In addition, we have not found any reports on the metastasis of sarcoid components, no matter what the composition is.
format Online
Article
Text
id pubmed-9909557
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-99095572023-02-10 Case report: Highly differentiated endometrial adenocarcinoma that collided with uterine cervical carcinosarcoma Fan, Xue Hu, Haoyue Liu, Yang Tan, Songtao Xie, Meng Zhang, Fang Front Med (Lausanne) Medicine Uterine collision tumor is a rare pathological type composed of two or more malignant tumors. The components of these malignant tumors do not have histological mixing and are separated by the normal mesenchyme. Collision cancer is very rare, with uterine collision tumors being even rarer. Only a few cases have been reported in relation to uterine collision tumors. At present, there is no standard treatment guideline for uterine collision tumors, and a comprehensive treatment composed of surgery, radiotherapy, and chemotherapy is suggested. In this study, we report a 54-year-old female patient diagnosed with highly differentiated endometrial adenocarcinoma with cervical carcinosarcoma. The endometrial adenocarcinoma component invaded the deep myometrium (> 1/2 layer), involving the cervical glands and interstitium. The regional lymph node metastasis from endometrial adenocarcinoma was also detected. The patient underwent “transabdominal tumor cytoreduction (total hysterectomy + right adnexal resection + greater omentectomy + pelvic lymph node dissection + para-aortic lymph node dissection) + pelvic adhesion release.” In addition, she has completed adjuvant radiotherapy and chemotherapy. After reviewing previous reports of collision tumors in different positions of the uterus, we found that collision tumors between the cervix and uterine body are very uncommon. In addition, we have not found any reports on the metastasis of sarcoid components, no matter what the composition is. Frontiers Media S.A. 2023-01-26 /pmc/articles/PMC9909557/ /pubmed/36778737 http://dx.doi.org/10.3389/fmed.2023.1044196 Text en Copyright © 2023 Fan, Hu, Liu, Tan, Xie and Zhang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Fan, Xue
Hu, Haoyue
Liu, Yang
Tan, Songtao
Xie, Meng
Zhang, Fang
Case report: Highly differentiated endometrial adenocarcinoma that collided with uterine cervical carcinosarcoma
title Case report: Highly differentiated endometrial adenocarcinoma that collided with uterine cervical carcinosarcoma
title_full Case report: Highly differentiated endometrial adenocarcinoma that collided with uterine cervical carcinosarcoma
title_fullStr Case report: Highly differentiated endometrial adenocarcinoma that collided with uterine cervical carcinosarcoma
title_full_unstemmed Case report: Highly differentiated endometrial adenocarcinoma that collided with uterine cervical carcinosarcoma
title_short Case report: Highly differentiated endometrial adenocarcinoma that collided with uterine cervical carcinosarcoma
title_sort case report: highly differentiated endometrial adenocarcinoma that collided with uterine cervical carcinosarcoma
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909557/
https://www.ncbi.nlm.nih.gov/pubmed/36778737
http://dx.doi.org/10.3389/fmed.2023.1044196
work_keys_str_mv AT fanxue casereporthighlydifferentiatedendometrialadenocarcinomathatcollidedwithuterinecervicalcarcinosarcoma
AT huhaoyue casereporthighlydifferentiatedendometrialadenocarcinomathatcollidedwithuterinecervicalcarcinosarcoma
AT liuyang casereporthighlydifferentiatedendometrialadenocarcinomathatcollidedwithuterinecervicalcarcinosarcoma
AT tansongtao casereporthighlydifferentiatedendometrialadenocarcinomathatcollidedwithuterinecervicalcarcinosarcoma
AT xiemeng casereporthighlydifferentiatedendometrialadenocarcinomathatcollidedwithuterinecervicalcarcinosarcoma
AT zhangfang casereporthighlydifferentiatedendometrialadenocarcinomathatcollidedwithuterinecervicalcarcinosarcoma